Clover Health CLOV 深 沪
等待开盘 08-18 09:30:00 美东时间
4.235
-0.365
-7.93%
华盛通- 最 高4.57
- 今 开4.55
- 成交量 449.50万股
- 最 低 4.15
- 昨 收 4.60
- 总市值 224.09万
- 52周最高 5.59
- 市盈率 静 --
- 换手率 0.85%
- 52周最低 1.58
- 委 比 -13.41%
- 总股本 0.01亿
- 历史最高 28.85
- 量 比 1.13
- 振 幅 9.13%
- 历史最低 0.606
- 每 手 1
- 风险率 0.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocity against fu...
08-10 20:49
财报速睇 | Clover Health 2026财年Q2营收7.43亿美元，同比增长55.6%；归母净利润0.28亿美元，扭亏为盈
华盛资讯8月7日讯，Clover Health公布2026财年Q2业绩，公司Q2营收7.43亿美元，同比增长55.6%，归母净利润0.28亿美元，扭亏为盈。
08-07 20:17
期权扫描 | 利空落地？SpaceX解禁后大涨！多张末日Put单“一夜归零”
利空落地？SpaceX解禁后大涨！多张末日Put单“一夜归零”；赫兹租车绩后狂飙近30%，期权成交放量逾11倍！超八成期权押注后市续涨>>
08-07 19:20
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
财报速睇 | Clover Health 2026财年Q2营收7.43亿美元，同比增长55.6%；归母净利润0.28亿美元，扭亏为盈
华盛资讯8月6日讯，Clover Health公布2026财年Q2业绩，公司Q2营收7.43亿美元，同比增长55.6%，归母净利润0.28亿美元，扭亏为盈。
08-06 08:46
Clover Health Investments shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates.
Clover Health Investments shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates.
08-06 04:56
Clover Health Investments Q2 EPS $0.05 Beats $0.03 Estimate, Sales $743.167M Beat $728.267M Estimate
Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 350 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $743.167...
08-06 04:14
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
Canaccord Genuity Maintains Buy on Clover Health Investments, Raises Price Target to $5.5
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and raises the price target from $4.2 to $5.5.
07-21 19:19
Clover Health Reports Cybersecurity Incident, Enhances Protections
Clover Health Investments ( ($CLOV) ) has issued an update. On July 4, 2026, Cl...
07-18 05:34
